Cardinal Health will release its second-quarter financial results for fiscal 2026 on February 5, prior to the opening of trading on the New York Stock Exchange. The company has scheduled a live webcast discussion of these results at 8:30 a.m. Eastern, providing investors with real-time commentary from senior management. This timing allows market participants to analyze the company’s performance before market open and adjust their positions accordingly.

Investors can access the webcast and the accompanying slide presentation through Cardinal Health’s Investor Relations page without an access code. The slide deck and a replay of the webcast will remain available on the same page for 12 months, enabling analysts and institutional shareholders to review the detailed discussion of segment performance, cash flow metrics and strategic initiatives at their convenience.

Cardinal Health operates two primary segments—Pharmaceutical and Medical. The Pharmaceutical segment distributes branded, generic and specialty pharmaceuticals, operates radiopharmaceutical manufacturing facilities and nuclear pharmacies, and provides pharmacy management services. The Medical segment manufactures and distributes medical, surgical and laboratory products—including exam gloves, surgical drapes and fluid management systems—while offering supply chain solutions to hospitals and outpatient centers. The company’s customer-centric strategy emphasizes continuous process improvement and data-driven solutions to enhance operational efficiency and drive long-term revenue growth.